2025年11月26日，Candela经典技术回响暨Glacē Treatment星钻光新品发布会在上海静安洲际酒店启幕，发布会以"星向 寰宇·美自新生"为主题。本次大会延续Candela'星海征途'主题，汇聚了全国医美专家与运营精英，共溯经典技术积 淀，共探双美融合新程。 以经典技术为基，以临床精研为径，共筑医疗价值新生态 Candela亚太区商务高级副总裁 Indra Suardi 以"致美无界，共赴星河"为题发表开幕致辞。他指出："Candela拥有55年历 史，始终坚持两件事：第一，用科技推动医美进步；第二，与医生并肩，为人们创造更美的未来。"他强调，本次大 会不仅是对经典技术的回望，更是对行业未来的承诺。"2026年，让我们继续携手——用心打磨好产品，同心创造新 未来！" 随后，四位行业专家分别从不同维度分享了与Candela经典技术相互成就的临床历程： 上海交通大学医学院附属第九人民医院周国瑜教授演讲主题是《血管领域的基石：我与脉冲染料激光四十年的相互成 就》。周教授回顾了与Vbeam脉冲染料激光结缘数十年来的临床历程，通过一系列经典病例，阐释了该技术治疗血管 疾病的有效性。 卓正医疗北京睿清诊所 ...

Core Viewpoint - The skincare industry is increasingly integrating with medical aesthetics, with products like eye creams and moisturizers claiming to deliver results comparable to professional treatments, offering consumers effective, convenient, and safe alternatives to invasive procedures [3][4][16]. Group 1: Industry Trends - Brands are collectively launching "clinic-level" skincare products, blurring the lines between home care and medical aesthetics, raising questions about the definition of "effective" skincare [4][16]. - The demand for "clinic-level" products is driven by consumers seeking high efficacy without the invasiveness and cost of medical procedures, reflecting a shift in consumer preferences towards more accessible skincare solutions [19][22]. Group 2: Technological Innovations - The industry is focusing on three main technological pathways: ingredient replication, transdermal technology, and efficacy validation to bridge the gap between professional medical aesthetics and daily skincare [5][11]. - Ingredient replication involves incorporating medical-grade ingredients into skincare products, such as PDRN, which traditionally required injection for effectiveness but is now being formulated for topical use [5][7]. - Transdermal technology advancements aim to enhance the absorption of active ingredients, allowing skincare products to penetrate deeper into the skin without invasive methods [9][11]. Group 3: Efficacy Validation - Brands are increasingly relying on robust efficacy data to support their claims, conducting human efficacy tests and correlating results with medical aesthetic procedures to build consumer trust [11][13]. - The lack of a unified efficacy validation system poses challenges, as current testing methods and metrics vary, making it difficult to compare results with established medical treatments [27][29]. Group 4: Market Dynamics - The light medical aesthetics market in China has seen a compound annual growth rate (CAGR) of over 20% from 2018 to 2023, with projections indicating it will exceed 250 billion RMB by 2025 [20]. - The integration of medical aesthetics and skincare is becoming a significant trend, with brands exploring collaborations and innovations that combine both fields to meet consumer demands for effective and safe skincare solutions [24][28]. Group 5: Consumer Behavior - Consumers are becoming more discerning, seeking scientific evidence and efficacy data behind claims of products that promise results similar to medical treatments, indicating a maturation of the market [26][29]. - The shift towards "clinic-level" skincare reflects a broader trend of consumers desiring effective, convenient, and safe alternatives to traditional medical aesthetics, creating a new ecosystem in the beauty industry [24][29].

Core Viewpoint - The article discusses the launch of Estée Lauder's new eye cream, the "Micro-Sculpting Eye Cream," which aims to bridge the gap between cosmetic and medical beauty, addressing long-standing consumer pain points in eye care and leading the trend of dual beauty integration [3][4][28]. Market Context - The eye care market in China is experiencing rapid growth and intense competition, with increasing consumer demand for youthful appearance, particularly among younger demographics and men [23][24]. - The market for eye care products is evolving from basic moisturizing tools to "precise anti-aging solutions," driven by the integration of medical aesthetics and daily care [23][24]. Product Launch and Features - Estée Lauder's new eye cream is positioned as a "clinic-level anti-aging" product that simulates three major cosmetic procedures: Botox, Thermage, and hyaluronic acid fillers [16][27]. - The cream incorporates advanced technologies, including a blend of peptides and hyaluronic acid, to achieve effects similar to those of medical procedures without the associated side effects [16][19][20]. Consumer Insights - The demand for eye area rejuvenation is increasing, with consumers prioritizing safety, long-lasting effects, and comprehensive anti-aging solutions [6][12]. - The product aims to empower consumers to take proactive steps in their daily skincare routines, moving away from reliance on medical procedures [27][28]. Scientific Backing - Clinical trials presented at a leading dermatology conference demonstrated the effectiveness of the new eye cream in improving the appearance of the eye area, with significant percentages of participants reporting visible improvements [21][20]. - The product's formulation is supported by over 40 years of research and development in nighttime repair and eye care, establishing a strong scientific foundation for its claims [24][27]. Competitive Positioning - Despite competition from domestic brands and white-label products, Estée Lauder maintains a leading position in the eye care market, evidenced by its top sales figures in online platforms [23][24]. - The brand's long-standing commitment to research and innovation has allowed it to stay at the forefront of the eye care segment, continuously adapting to market trends and consumer needs [24][27].

Core Viewpoint - The beauty industry is increasingly entering the medical aesthetics channel, with over 20 beauty brands adopting a dual beauty strategy of "medical aesthetics + beauty" to enhance their market presence and professional credibility [2][6][30]. Group 1: Market Overview - The medical aesthetics market in China is experiencing strong growth, with 18,584 compliant specialized medical aesthetics institutions reported as of January 2024 [6][7]. - The main active regions for medical aesthetics consumption are concentrated in the Pearl River Delta, Yangtze River Delta, and Chengdu-Chongqing areas [7][8]. Group 2: Industry Structure - Medical aesthetics institutions can be categorized into three types: public hospitals, large chain private hospitals, and small private hospitals and clinics [4][5]. - The development of the domestic medical aesthetics industry has gone through three main stages: initiation (1994-2000), gradual standardization (2000-2010), and rapid development (2010-present) [5]. Group 3: Brand Strategies - Many beauty companies have established significant medical aesthetics channel layouts, such as Huaxi Biological covering 7,000 medical institutions and Juzhi Biological entering approximately 1,700 public hospitals and 3,000 private hospitals and clinics [8][10]. - International beauty brands are also accelerating their medical aesthetics channel expansion, with brands like SkinCeuticals and Estée Lauder entering high-end medical aesthetics lines [10][12]. Group 4: Consumer Trends - There is a growing consumer demand for effective skincare solutions that combine beauty products with medical treatments, reflecting a trend towards the integration of lifestyle beauty and medical aesthetics [17][20]. - Consumers are increasingly seeking products with professional medical backing and comprehensive management solutions from pre-operative care to post-operative recovery [18][20]. Group 5: Challenges and Opportunities - Despite the initial success of some brands in the medical aesthetics channel, challenges remain, including product quality inconsistency and the need for effective consumer education [16][18][20]. - The dual beauty model is becoming a significant trend, with medical aesthetics companies also venturing into lifestyle beauty, leveraging their technical expertise and clinical data [22][23]. Group 6: Future Outlook - The competition in the medical aesthetics channel is expected to intensify, with beauty brands needing to establish unique advantages through solid technical research and deep medical collaboration [29][30]. - The future winners in this space will be those who can embed "professional trust" in the medical aesthetics channel and leverage "real clinical value" to gain endorsements from both doctors and consumers [30].